6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
4m ago	Colgate, in partnership with Hong Kong Dental Association, launches TOTAL Periodontal Health Lab
30m ago	Navios Maritime Partners L.P. Announces First Day of Trading of Bonds at Euronext Oslo Børs
30m ago	Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
31m ago	Fiverr Announces First Quarter 2026 Results

About

Bright Minds Biosciences Inc (CN:DRUG) — investor relations, events, news, and company updates on 6ix.

Latest News

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

Financials

Revenue

CA$0

Market Cap

CA$958.75 M

EPS

-2.76

Community Chat

Ask AI